Press time:2015-03-04From: [ Font:BigMediumSmall]
In April 2014, CR Double-crane ANDA product Meloxicam and Wanhui Double-crane cGMP management protocol has been inspected on-site by US FDA officer for 5 days, and the final on-site report suggest as “zero defect”. After 8 months wait, in Dec 2014, CR Double-crane received US FDA approve letter. Besides, CR Double-crane also passed EU GMP on-site inspection in Mar 2013. This is a big milestone for CR Double-crane internationalization and also a begning of entering global competition.
